Physician profile
Robert Johnston
NPI 1255345971
$1,705.14
in general payments reported to CMS, 2019-2025
22 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2020: $104 · 2021: $52.35 · 2022: $350 · 2023: $124 · 2024: $323 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $658.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $376.61 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $281.93 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $280.58 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $237.15 | 2019-2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $93.54 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.29 | 2019-2024 | Synjardy, Jardiance |
| Exact Sciences Corporation | $54.29 | 2025 | Cologuard Collection Kit |
| Dexcom, INC. | $40.26 | 2024-2025 | Dexcom G6 Transmitter |
| Genentech USA, INC. | $39.99 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.64 | 2019 | |
| Xeris Pharmaceuticals, INC. | $20.07 | 2024 | Gvoke Hypopen |
| Glaxosmithkline, LLC. | $19.95 | 2025 | Trelegy Ellipta |
| Teva Pharmaceuticals USA, INC. | $17.99 | 2019 | |
| Abbott Laboratories | $17.95 | 2020 | |
| Pfizer INC. | $16.82 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $16.56 | 2019 | |
| Astellas Pharma US INC | $16.10 | 2019 | |
| Merck Sharp & Dohme LLC | $15.60 | 2019 | |
| Boston Scientific Corporation | $15.22 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.20 | 2022 | |
| Allergan, INC. | $12.82 | 2019 | |
| Horizon Therapeutics Plc | $12.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.